angiotensin II-receptor blocker, telmisartan
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2004 Nov 4;351(19):1952-61 Randomized Controlled Trial, Multicenter Study
IN diabetes mellitus, type 2, early nephropathy The Use of
angiotensin II-receptor blocker, telmisartan
As Treatment, Chronic
Is equal Than
angiotensin converting-enzyme ACE inhibitor, enalapril
To reduce loss of glomerular filtration (-18 ml/min in ARA-II VS -15 ml/min in ACE inhibitors, for a mean body-surface area) or to reduce urinary albumin excretion and blood pressure - all at 5 years